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Abstract
We describe a method for mapping quantitative trait loci that allows for locus heterogeneity. A
genome-wide linkage analysis of blood pressure was performed using sib-pair data from the
Framingham Heart Study. Evidence of linkage was found on four markers (GATA89G08,
GATA23D06, GATA14E09, and 049xd2) at a significance level of 0.01. Two of them (GATA14E09
and 049xd2) seem to overlap with linkage signals reported previously, while the other two are not
linked to any known signals.
Background
High blood pressure (BP) is an important risk factor for
cardiovascular disease and is a leading cause of mortality
in industrialized countries [1]. Being a complex trait, BP
may be influenced by genes at different locations on the
genome in different families (inter-family locus heteroge-
neity). Presumably, allowing for locus heterogeneity in
the analysis will increase the power to detect linkage.
We propose a model that allows for locus heterogeneity
for quantitative trait loci (QTLs). This model generalizes
the locus heterogeneity model for qualitative traits [2,3]
to the case of continuous traits. A genome-wide linkage
analysis was conducted on the Framingham Heart Study
data using the likelihood-ratio statistic based on this
model.
Methods
Data
The Framingham Heart Study consists of two cohorts with
a total of 10,333 subjects. The first cohort includes 5209
individuals who were recruited initially in 1948 when the
study began. The second cohort includes 5124 subjects
who are offspring, or spouses of offspring, of the initial
participants. Longitudinal data were recorded over follow-
up years in both cohorts. In the total 330 pedigrees pro-
vided by the Genetic Analysis Workshop 13 (GAW13),
1702 subjects were genotyped at at least one marker and
2885 subjects were phenotyped for BP at least once.
To remove the effect of hypertension treatment, we
focused only on those subjects who never received any
antihypertensive medication. There are 1909 such sub-
jects. Their characteristics are summarized in Table 1. The
systolic blood pressures were adjusted for age, sex, and
body mass index (BMI) in the following manner. The
averages of BP, age, and BMI were computed for each sub-
ject, and then the average of BP was regressed over those
of age and BMI as well as sex, separately for each of the
two cohorts. The residuals of the simple linear regression
were used as the (adjusted) phenotypic values. The two-
point identity-by-descent (IBD) sharing probabilities on
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relative pairs provided by GAW13 were used. Only sib
pairs were used in the analysis. Sib pairs from the same
sibship or from different sibships in the same pedigree
were treated as if they were biologically unrelated.
A total of 400 markers were used in the genome scan. Not
all sib pairs were genotyped at every marker. So the
number of sib pairs used in the analysis varied from
marker to marker, roughly from 400 to 1500.
Significant departure from normality was detected on the
(adjusted) BP measurement using the Shapiro-Wilk test
(p-value < 0.0001). To reduce the impact of the non-nor-
mality of the data on the performance of the proposed sta-
tistic, the BP measurements were transformed based on
the normal copula model [4] so the transformed trait val-
ues follow a standard normal distribution, with a mean
and variance of 0 and 1, respectively.
Statistical methods
Consider a sib pair whose trait values are denoted by y1
and y2, respectively. The trait values are standardized such
that they have mean 0 and variance 1. It is assumed that
the candidate locus has an additive effect but no domi-
nance effect on the trait. Let ρ0, ρ1, and ρ2 be the correla-
tion coefficients of y1 and y2 when the number of alleles
that are shared IBD by the sib pair is 0, 1, and 2, respec-
tively. Because there is no additive effect, we have ρ1 = (ρ0
+ ρ2)/2 [4]. When there is no linkage, ρ1 can be estimated
by taking the value of correlation coefficient between y1
and y2 [5,6]. So ρ1 can be treated as known.
Conditional on the IBD sharing status, y1  and  y2  are
assumed to have a bivariate normal distribution, which is
completely characterized by the correlation coefficients
ρ0, ρ1, or ρ2. Let π0, π1, and π2 be the probabilities that the
sib pair shares 0, 1, or 2 alleles IBD, respectively, and then
the likelihood function for y1 and y2 is
L(ρ2; y1, y2) = π0 φ (y1, y2; 2ρ1 - ρ2) + π1 φ (y1, y2; ρ1) + π2 φ
(y1, y2; ρ2),
where φ(·,·;·) denotes the density function of a bivariate
normal distribution. When the candidate locus is not
linked to any QTL, ρ1 =  ρ2 and the above likelihood
reduces to L(ρ1; y1,y2) = φ(y1, y2; ρ1). Otherwise, ρ2 > ρ1.
Let α be the probability that a QTL is linked to the candi-
date locus for the sib pair. Then the likelihood function
for the sib pair would be
α L(ρ2; y1, y2) + (1 - α)L(ρ1; y1, y2).
Let i index the ith sib pair in a collection of sib pairs, then
the log-likelihood function for these sib pairs is
l(α, ρ2) = Σi log[α L(ρ2; yi1, yi2) + (1 - α)L(ρ1; yi1, yi2) ],
where yi1 and yi2 are the trait values for the ith sib pair. The
hypotheses of interest are
H0: ρ2 = ρ1, α ∈ [0,1] vs. H1: ρ2 > ρ1, α ∈ [0,1]
This model is an extension of the heterogeneity model of
Smith [2] for dichotomous traits to continuous traits. The
likelihood ratio statistic was used as the test statistic. To
obtain the maximum likelihood estimates (MLEs) of
parameters, we used a two-dimensional grid search over α
and ρ2, with the grid size of 0.01 for both parameters.
The asymptotic distribution of the likelihood ratio statis-
tic is not known analytically. So a simulation study with
10,000 replicates was carried out. The trait locus is
assumed to have two equally frequent alleles and its her-
itability is set to 0.3. The unlinked marker is assumed to
be fully polymorphic. The 90th, 95th, 99th, and 99.9th per-
centiles of the distribution are found to be 2.72, 3.91,
6.61, and 11.07, respectively.
Results
A genome scan is conducted using three statistics: the test
statistic of Haseman-Elston method (H-E) [7], the likeli-
hood ratio statistic (HET-LRT) for the heterogeneity
model described above, and the likelihood ratio statistic
(HOM-LRT) for the homogeneity model, which is a spe-
cial case of the heterogeneity model with α fixed at 1. The
markers that are significant for at least one statistic at sig-
nificance level 0.01 are listed in Table 2.
Table 1: Summary statistics for subjects in Cohort 1 and Cohort 2 (standard errors are in parentheses)
Number by Gender
Cohort Male Female Total Age (yr) BMI (kg/m2)S B P  ( m m  H g )
1 304 269 573 56.0 (7.4) 25.7 (3.7) 130.1 (16.1)
2 659 677 1336 40.9 (10.1) 25.5 (4.3) 118.5 (12.3)BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S78
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At significance level 0.01, four significant markers are
identified by statistic HET-LRT. Among the four markers,
GATA14E09 on chromosome 8 is very close to 8q21.11, a
region that showed linkage to BP [8]. 049xd2 on chromo-
some 16 is between 16p12 and 16p13.1, a region in
which linkage to BP was found by two independent stud-
ies [8,9]. To the best of our knowledge, the other two
markers, i.e., GATA89G08 on chromosome 5 and
GATA23D06 on chromosome 8, do not link to any previ-
ous findings.
Discussion
We introduce a heterogeneity model for mapping QTLs
using sib-pair data. A genome scan was performed to map
QTLs affecting BP variation on a population-based data
using this new method. At significance level 0.01, evi-
dence of linkage is found in four marker regions on chro-
mosomes 5, 8, and 16. Two of the markers seem to
overlap with linkage signals in previous studies, while the
other two are not linked to any previous findings.
Of the three statistics used in the genome scan, H-E pro-
vides the most linkage signals, followed by HOM-LRT,
and then by HET-LRT. At the four markers at which HET-
LRT is significant (and at many nonsignificant markers
that are not shown), the statistic value of HET-LRT is the
same as that of HOM-LRT. Finer grid size may change the
values of HOM-LRT and HET-LRT, but the changes are
expected to be small. Experiments on the four significant
markers with grid size 0.001 strongly support this claim.
In these experiments, HET-LRT is still the same as HOM-
LRT for all four markers.
The proposed statistic HET-LRT is intended for a popula-
tion sample. Its performance under selected samples is
unknown. Although the normal copula model can be
used on selected samples to recover normality, its
effectiveness has yet to be investigated. It is worthwhile to
point out that our analysis has excluded individuals on
antihypertensive medication. Therefore, careful attention
should be paid when generalizing our results to general
population. For a recent review on the issues dealing with
antihypertensive treatments, see Palmer [10].
We have been using the posterior probability of linkage
(PPL) to assess linkage signals across heterogeneous data
sets [11-14]. Since the proposed heterogeneity model for
quantitative traits is parallel to that for qualitative traits, it
is reasonable to adapt our previous work on qualitative
traits to the current setting. The details are being worked
out.
The proposed model is for sib-pair data only. It is expected
that the use of nonindependent sib-pairs, like what we did
in this analysis, does not affect the type I error rate asymp-
totically. It is of interest to see how this model can be gen-
eralized to general pedigrees and how the generalized
model performs.
Table 2: Significant markers at significance level 0.01 (p-values are in parentheses)
Marker Chr cM H-E HOM-LRT HET-LRT
GATA6F06 3 79 5.40 (0.009) 6.02 (0.007)
GATA28F03 4 73 7.42 (0.003)
GATA89G08 5 98 10.06 (0.001) 6.68 (0.005) 6.68 (0.009)
GATA23D06 8 26 6.99 (0.004) 6.68 (0.005) 6.68 (0.009)
GGAA20C10 8 60 6.45 (0.005)
GATA14E09 8 94 11.36 (0.0003) 6.76 (0.004) 6.76 (0.009)
GATA21C12 8 140 6.15 (0.006)
GATA62F03 9 14 10.88 (0.0004)
GGAA2F11 10 117 8.99 (0.001) 5.42 (0.010)
ATA29A06 12 161 10.79 (0.0004)
GATA13D05 12 166 6.50 (0.005)
GATA30A03 14 92 9.38 (0.001)
ATA3A07 16 23 7.64 (0.002) 5.39 (0.010)
049xd2 16 44 8.92 (0.001) 7.23 (0.003) 7.23 (0.007)
ATC6A06 17 67 5.50 (0.009)
ATA7D07 18 89 6.81 (0.004)
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